Biomanufacturing sales key to Pall’s Q4 growth
Pall has ended fiscal 2010 with strong set of sales after recovering pharmaceutical industry demand for bioproduction tech maintained its momentum in Q4
Archives for September 14, 2010
NexACT enables rectal delivery of biologics, say Apricus Bio
Apricus Biosciences, formerly NexMed, announce preclinical data shows NexACT technology enables rectal delivery of biologics, including human antibodies.
eClinical talks future of data management
Clinical data management is, and will continue to be a key concern for the pharmaceutical industry, according to Susan Bornstein, executive vice president of eClinical solutions, who discussed the issue with Outsourcing-pharma earlier this week.
Q Chip scaling up cGMP production using new funding
Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.
Gentronix deal boosts CRL’s genotoxicity service offering
Charles River Laboratories (CRL) is strengthening its genotoxicity screening service by offering Gentronix’s BlueScreen HC.